Division of Pathology & Laboratory Medicine's Grand Rounds
“New Insights into the MAP Kinase Pathway in Pancreatic Cancer”
Huamin Wang, MD, PhD
Associate Professor, Department of Pathology and
Department of Translational Molecular Pathology
Division of Pathology and Laboratory Medicine
The University of Texas MD Anderson Cancer Center
Friday, Sept. 5, 2014
8:00 – 9:00 a.m.
Russell Conf. Room, G1.3741
After attending this activity, the target audience of Pathologists, Clinical & Surgical Pathology trainees, Medical Technologists, Faculty, and other healthcare professionals from Pathology, Hematology, Cytology, Informatics, Thoracic, Transfusion Medicine, Clinical Chemistry and Sarcoma should be able to:
· Discuss and apply recent research and developments in the field of Laboratory Medicine/Clinical and Anatomical Pathology, Molecular Pathology and Hematopathology (knowledge, competence, performance).
· Compare current trends in Laboratory Medicine and Pathology Research and apply to clinical applications (knowledge, competence, performance).
· Evaluate and transfer experimental findings into clinical practice, particularly pertaining to Laboratory Medicine and Pathology (knowledge, competence, performance).
· Identify and combine important clinical and research areas of Laboratory Medicine and Pathology (knowledge, competence, performance).
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. It is the policy of The University of Texas MD Anderson Cancer Center that the program chair(s), planning committee member, faculty/teacher/ author, or CME activity reviewer must disclose any relevant financial relationships with commercial interests whose products may be discussed in the activities, if any. MD Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Date: 9/5/14, 8am to 9am
Time: 9/5/14, 8am to 9am
Location: Wm. O. Russell Conference Room (G1.3741)
Directions: Main Hospital, Alkek Building - 1st Floor near Elevator F (off of the Radiation hallway)
Format: Grand Rounds
CME: 1 AMA PRA Category 1 Credit
Speaker: Huamin Wang, MD, PhD
Contact: Andrea Daniel - (713) 745-7057 - email@example.com
Add event to my calendar